After Making the IPO Jump, Biotechs Landed On a Slippery Slope
Around 25 companies have gone public this year, most of them in the early months. Most have tumbled from their original offer price.
After Making the IPO Jump, Biotechs Landed On a Slippery Slope Read More »
